149 related articles for article (PubMed ID: 8965498)
1. [Domperidone: an alternative to orthopramides in the case of adverse reactions in the central nervous system].
Buzo Sánchez LG; Artacho Criado S; Navarro Pulido AM; Orta Cuevas JC
Med Clin (Barc); 1996 Sep; 107(8):317-8. PubMed ID: 8965498
[No Abstract] [Full Text] [Related]
2. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis.
Patterson D; Abell T; Rothstein R; Koch K; Barnett J
Am J Gastroenterol; 1999 May; 94(5):1230-4. PubMed ID: 10235199
[TBL] [Abstract][Full Text] [Related]
3. [Urinary retention in 2 children after the use of antiemetic agents during acute gastroenteritis].
de Moor RA; Diemont WL; Visser MO; van den Bemt PM
Ned Tijdschr Geneeskd; 2005 Jun; 149(26):1472-4. PubMed ID: 16010961
[TBL] [Abstract][Full Text] [Related]
4. Warnings on metoclopramide treatment.
Bernstein R
Clin Gastroenterol Hepatol; 2009 Oct; 7(10):1138; author reply 1138-9. PubMed ID: 19426834
[No Abstract] [Full Text] [Related]
5. Domperidone: QT prolongation in infants.
Prescrire Int; 2011 Jan; 20(112):14. PubMed ID: 21462787
[No Abstract] [Full Text] [Related]
6. Persistent generalized anxiety after brief exposure to the dopamine antagonist metoclopramide.
Kluge M; Schüssler P; Steiger A
Psychiatry Clin Neurosci; 2007 Apr; 61(2):193-5. PubMed ID: 17362439
[TBL] [Abstract][Full Text] [Related]
7. Familial acute dystonic-dyskinetic syndrome with dominant inheritance after use of antidopaminergic antiemetic drugs.
Macucci M; Dotti MT; Federico A
Mov Disord; 1995 Jul; 10(4):528-9. PubMed ID: 7565844
[No Abstract] [Full Text] [Related]
8. [A case of the successful use of Motilium in treating reflux disease against a background of the hypothalamic syndrome of traumatic origin].
Svintsyts'kyĭ AS; Dzeman MI; Shylo HV
Lik Sprava; 1999 Jun; (4):145-7. PubMed ID: 10476668
[No Abstract] [Full Text] [Related]
9. [Pharmacologic and clinical differentiation of prokinetic drugs].
May B; Greving I
Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601
[TBL] [Abstract][Full Text] [Related]
10. Domperidone: review of pharmacology and clinical applications in gastroenterology.
Reddymasu SC; Soykan I; McCallum RW
Am J Gastroenterol; 2007 Sep; 102(9):2036-45. PubMed ID: 17488253
[TBL] [Abstract][Full Text] [Related]
11. [Current role of antidopaminergic drugs in pediatrics].
Cinquetti M; Bonetti P; Bertamini P
Pediatr Med Chir; 2000; 22(1):1-7. PubMed ID: 11387760
[TBL] [Abstract][Full Text] [Related]
12. Domperidone: unapproved alternative to metoclopramide.
Abell TL; Tidd ME
J Am Pharm Assoc (2003); 2005; 45(4):420. PubMed ID: 16128491
[No Abstract] [Full Text] [Related]
13. Dosage and drug interactions of domperidone.
Robinson P
Am J Gastroenterol; 2008 Apr; 103(4):1049. PubMed ID: 18397438
[No Abstract] [Full Text] [Related]
14. [Gastroesophageal reflux in the newborn].
Urrusti-Sanz J
Gac Med Mex; 1995; 131(5-6):601-3. PubMed ID: 8768609
[No Abstract] [Full Text] [Related]
15. [Major gastrointestinal syndromes (2): dyspepsia or syndrome of the upper digestive system related with food (2)].
León-Barúa R; Berendson-Seminario R
Rev Gastroenterol Peru; 2008; 28(3):267-9. PubMed ID: 18958143
[TBL] [Abstract][Full Text] [Related]
16. A case of metoclopramide-induced oculogyric crisis in a 16-year-old girl with cystic fibrosis.
Lou E; Abou-Zeid N
South Med J; 2006 Nov; 99(11):1290-1. PubMed ID: 17195428
[TBL] [Abstract][Full Text] [Related]
17. [Severe parkinsonism due to metoclopramide in a patient with polypharmacy].
Hoogendam A; Hofmeijer J; Frijns CJ; Heeringa M; Schouten-Tjin a Tsoi SL; Jansen PA
Ned Tijdschr Geneeskd; 2002 Jan; 146(4):175-7. PubMed ID: 11845569
[TBL] [Abstract][Full Text] [Related]
18. Short-term effect of domperidone on gastroesophageal reflux in newborns assessed by combined intraluminal impedance and pH monitoring.
Cresi F; Marinaccio C; Russo MC; Miniero R; Silvestro L
J Perinatol; 2008 Nov; 28(11):766-70. PubMed ID: 18580879
[TBL] [Abstract][Full Text] [Related]
19. Domperidone: limited benefits with significant risk for sudden cardiac death.
Hondeghem LM
J Cardiovasc Pharmacol; 2013 Mar; 61(3):218-25. PubMed ID: 23188128
[TBL] [Abstract][Full Text] [Related]
20. [Extrapyramidal toxicity caused by metoclopramide and clebopride: study of voluntary notifications of adverse effects to the Spanish Drug Surveillance System].
Cuena Boy R; Maciá Martínez MA
Aten Primaria; 1998 Mar; 21(5):289-95. PubMed ID: 9608114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
